SCHEMBL3022801

SCHEMBL3022801

CCN(CC)c1ccccc1-c1ccccc1P(C1CCCCC1)C1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21788 0.84 HTR6 (0.36) MAPTL3MBTL1
SCHEMBL29354371 0.84 HTR6 (0.36) MAPTL3MBTL1
SCHEMBL29353225 0.84 HTR6 (0.36) MAPTL3MBTL1
SCHEMBL4988734 0.82 HTR6 (0.34) MAPTL3MBTL1
Bromide SCHEMBL1030113 0.81 HTR6 (0.35) MAPTL3MBTL1
SCHEMBL520084 0.81 BCHE (0.37) MAPT
SCHEMBL19469290 0.80 HTR6 (0.34) MAPTL3MBTL1
SCHEMBL2846314 0.79 L3MBTL1 (0.33) L3MBTL1
SCHEMBL1030115 0.79 HTR6 (0.33)
SCHEMBL28174897 0.79 HTR6 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10189996-B2 Anthracene-based organic dye NATIONAL CHI NAN UNIVERSITY (TW) 2019-01-29 US disclosed
US-20180289672-A1 SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITIORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2018-10-11 US disclosed
US-20180155549-A1 ANTHRACENE-BASED ORGANIC DYE NATIONAL CHI NAN UNIVERSITY (TW) 2018-06-07 US disclosed
US-20180155549-A1 ANTHRACENE-BASED ORGANIC DYE NATIONAL CHI NAN UNIVERSITY (TW) 2018-06-07 US disclosed
EP-2746271-B1 Phenyl-substituted 1, 3, 5-triazine compounds as intermediates for electroluminescent molecules TOSOH CORP (JP) 2016-08-17 EP disclosed
EP-2746271-A1 Phenyl-substituted 1, 3, 5-triazine compounds as intermediates for electroluminescent molecules Tosoh Corporation (JP) 2014-06-25 EP disclosed
EP-2141158-B1 PHENYL-SUBSTITUTED 1,3,5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT TOSOH CORP (JP) 2014-05-07 EP disclosed
US-8569485-B2 Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component TOSOH CORPORATION (JP) 2013-10-29 US disclosed
US-20120313090-A1 PHENYL-SUBSTITUTED 1,3,5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2012-12-13 US disclosed
US-8268997-B2 Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component TOSOH CORPORATION (JP) 2012-09-18 US disclosed
US-20100249406-A1 PHENYL-SUBSTITUTED 1,3.5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT TOSOH CORPORATION (JP) 2010-09-30 US disclosed
US-7745483-B2 2-Halofuryl-thienyl-3-carboxamides BAYER CROPSCIENCE AG (DE) 2010-06-29 US disclosed
EP-2141158-A1 PHENYL-SUBSTITUTED 1,3,5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT Tosoh Corporation (JP) 2010-01-06 EP disclosed
US-20080064874-A1 2-Halofuryl/Thienyl-3-Carboxamides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064874-A1 2-Halofuryl/Thienyl-3-Carboxamides HDHD5, HACL2, MRPL21 DDB1 4121/4885CRBN 707/4885MAPT 2409/4885
US-20100249406-A1 PHENYL-SUBSTITUTED 1,3.5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT H1-5, H1-4, H1-2 DDB1 2856/4885CRBN 1976/4885MAPT 3383/4885
US-20180289672-A1 SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITIORS MAP3K20, MAP3K1, MAP3K5 DDB1 1070/4885CRBN 596/4885MAPT 2515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.